Soluble CD antigen (cytokine) expression in various hyperthyroid states and use in the assessment of propylthiouracil treatment

References

1. • Lynch RG
   • Sandor M
   • Nunez R
   • et al.
   Lymphocyte Fc receptors: the immunobiology and pathology of CD23.
   Immunobiology. 1992; 185: 235-267
   • Google Scholar
2. • Fujimoto J
   • Levy S
   • Levy R
   Spontaneous release of the Leu 2(T8) molecule from human T cells.
   J Exp Med. 1983; 158: 752-766
   • Google Scholar
3. • Sarfati M
   • Rector E
   • Wong K
   • Rubio-Trujillo M
   • Schon AH
   • Delespesse G
   Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE.
   J Immunol. 1988; 141: 495-499
   • Google Scholar
4. • Rubin LA
   • Kurman CC
   • Fritz ME
   • et al.
   Soluble interleukin-2 receptors are shed by activated human lymphocytes in vitro.
   in: Fed Proc. 44. 1985: 946
   • Google Scholar
5. • Smith BR
   • McLachlan SM
   • Furmaniak J
   Autoantibodies to the thyrotropin receptor.
   Endocr Rev. 1988; 9: 106-121
   • Google Scholar
6. • Rubin LA
   • Nelson DL
   The soluble interleukin-2 receptor: biology, function and clinical application.
   Ann Intern Med. 1990; 113: 619-627
   • Google Scholar
7. • Balasz CZ
   • Farid NR
   Soluble interleukin-2 receptor in sera of patients with Graves' disease.
   J Autoimmun. 1991; 4: 681-688
   • Google Scholar
8. • Chow CC
   • Lai KN
   • Leung JCK
   • Chan JCN
   • Cockram CC
   Serum soluble interleukin-2 receptors in hyperthyroid Graves' disease and effect of carbimazole therapy.
   Clin Endocrinol. 1990; 33: 317-321
   • Google Scholar
9. • Wilson R
   • McKillop JH
   • Buchanan LM
   • Bradley H
   • Smith WE
   • Thomson JA
   The effect of carbimazole therapy on interleukin-2, interleukin-2 receptors and free radicals.
   Autoimmunity. 1990; 8: 3-7
   • Google Scholar
10. • Prummel MF
    • Wiersinga WM
    • VanDerGaag R
    • Mourits MP
    • Koornneef L
    Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy.
    Clin Exp Immunol. 1992; 88: 405-409
    • Google Scholar
11. • Tomkinson BE
    • Brown MC
    • Ip SH
    • Carrabis S
    • Sullivan JL
    Soluble CD8 during T cell activation.
    J Immunol. 1989; 142: 2230-2236
    • Google Scholar
12. • Gordon J
    • Guy GR
    The molecules controlling B lymphocytes.
    Immunol Today. 1987; 8: 339-344
    • Google Scholar
13. • Pui CH
    • Ip SH
    • Dodge RK
    • et al.
    Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.
    Blood. 1988; 72: 1015-1021
    • Google Scholar
14. • Pui CH
    • Ip SH
    • Thompson E
    • et al.
    Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome.
    Blood. 1988; 73: 209-213
    • Google Scholar
15. • Genot E
    • Sarfati M
    • Sigaux F
    • et al.
    Effect of interferon-a on the expression and release of CD23 molecule in hairy cell leukemia.
    Blood. 1989; 74: 2455-2463
    • Google Scholar
16. • Fujimoto J
    • Stewart ST
    • Levy R
    Immunochemical analysis of the released Leu-2 (T8) molecule.
    J Exp Med. 1984; 160: 116
    • Google Scholar
17. • Agostini C
    • Semenzato G
    • Vinante F
    • et al.
    Increased levels of soluble CD8 molecules in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders.
    Clin Immunol Immunopathol. 1989; 50: 146
    • Google Scholar
18. • Reddy MM
    • Lange M
    • Greico MH
    Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.
    J Clin Microbiol. 1989; 27: 257-260
    • Google Scholar
19. • Lai RB
    • Ramzy RM
    • Gad AA
    Elevated levels of soluble CD8 molecules in patients with lymphatic filariasis.
    Immunol Lett. 1990; 26: 85
    • Google Scholar
20. • Ho AD
    • Grossman M
    • Trumper L
    • et al.
    Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia.
    Blood. 1990; 75: 1119-1124
    • Google Scholar
21. • Symons JA
    • Wood NC
    • Di Giovine FS
    • Duff GW
    Soluble CD8 in patients with rheumatic diseases.
    Clin Exp Immunol. 1990; 80: 354-359
    • Google Scholar
22. • Cairns J
    • Flores-Romo L
    • Millsum MJ
    • et al.
    Soluble CD23 is released by B lymphocytes cycling in response to interleukin-4 and anti-Bp50 (CDW 40).
    Eur J Immunol. 1988; 18: 349-353
    • Google Scholar
23. • Sarfati M
    • Bron D
    • Lagneaux L
    • Fonteyn C
    • Frost H
    • Delespesse G
    Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia.
    Blood. 1988; 71: 94-98
    • Google Scholar
24. • Bansal A
    • Roberts T
    • Hay EM
    • Kay R
    • Pumphrey RSH
    • Wilson PB
    Soluble CD23 levels are elevated in the serum of patients with primary Sjogren's Syndrome and systemic lupus erythematosus.
    Clin Exp Immunol. 1992; 89: 452-455
    • Google Scholar
25. • Small T
    • Keever C
    • Weiner-Fedus S
    • Heller G
    • O'Reilly R
    • Flomenberg N
    B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny.
    Blood. 1990; 76: 1647-1656
    • Google Scholar
26. • Komp DM
    • Shapiro E
    • McNamara J
    Soluble interleukin-2 receptor in childhood non-Hodgkin's Syndrome.
    Blood. 1988; 31: 1172-1173
    • Google Scholar
27. • Wagner DK
    • Kiwanuka J
    • Edwards BK
    • Rubin LA
    • Nelson DL
    • Magrath IT
    Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas correlation with survival.
    J Clin Oncol. 1987; 5: 1262-1267
    • Google Scholar
28. • Steis RG
    • Marcon L
    • Clark J
    • et al.
    Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia.
    Blood. 1987; 71: 1304-1309
    • Google Scholar
29. • Chilosi M
    • Semenzato R
    • Cetto G
    • et al.
    Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of alpha-interferon therapy on clinical parameters and on natural killer in vitro activity.
    Blood. 1987; 70: 1530-1535
    • Google Scholar
30. • Prince HE
    • Kleinman SH
    • Maino VC
    • Jackson AL
    In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin-2 receptor (IL-2R) production parallels cellular IL-2R expression and DNA synthesis.
    J Clin Immunol. 1988; 8: 114-120
    • Google Scholar
31. • Reddy MM
    • Grieco MH
    Elevated interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations.
    Aids Res Hum Retroviruses. 1988; 4: 115-120
    • Google Scholar
32. • Mahida YR
    • Gallagher A
    • Kurlak L
    • Hawkey CJ
    Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease.
    Clin Exp Immunol. 1990; 82: 75-80
    • Google Scholar
33. • Colvin RB
    • Fuller TC
    • MacKleen L
    • Rung S
    • Ip SH
    • Cosimi AB
    Plasma interleukin-2 receptor levels in renal allograft recipients.
    Clin Immunol Immunopathol. 1987; 43: 273-276
    • Google Scholar
34. • Rubini LA
    The soluble interleukin-2 receptor in rheumatic disease.
    Arthritis Rheum. 1990; 33: 1145-1148
    • Google Scholar
35. • Nelson DL
    • Rubin LA
    • Kurman CC
    • Fritz ME
    • Boutin B
    Soluble interleukin-2 receptors: analysis in normal individuals and in certain disease states.
    in: Fed Proc. 45. 1986: 377
    • Google Scholar
36. • Young ET
    • Steel NR
    • Taylor JJ
    • Stephenson AM
    • et al.
    Prediction of remission after antithyroid drug treatment in Graves' disease.
    QJ Med. 1988; 250: 175-189
    • Google Scholar
37. • Hufner M
    • Wermann M
    • GruBendorf M
    • Heilig B
    Is soluble CD25 antigen (interleukin-2 receptor) a useful parameter for differential diagnosis of thyrotoxicosis?.
    Clin Invest. 1992; 70: 122-124
    • Google Scholar
38. • Wilson R
    • McKillop JH
    • Pearson C
    • Burnett AK
    • Thomson JA
    Differential immunosuppressive action of carbimazole and propylthiouracil.
    Clin Exp Immunol. 1988; 73: 312-315
    • Google Scholar
39. • Wilson R
    • McKillop JH
    • Henderson N
    • Pearson DW
    • Thomson JA
    The ability of the serum thyrotropin antibody (TRAb) index and HLA status to predict long term remission of thyrotoxicosis following medical therapy for Graves' disease.
    Clin Endocrinol. 1986; 25: 151
    • Google Scholar
40. • Maccia E
    • Concetti R
    • Borgoni F
    • Fenzi GF
    • Pinchlia A
    Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: Their incidence, significance and clinical usefulness.
    Autoimmunity. 1989; 3: 103-112
    • Google Scholar
41. • Czarnocka B
    • Ruf J
    • Ferrand M
    • Carayon P
    • Lissitzky S
    Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid disease.
    FEBS Lett. 1985; 190: 147-152
    • Google Scholar
42. • Takaichi Y
    • Tamai H
    • Honda K
    • Nagai K
    • et al.
    The significance of antithyroglobulin and antithyroidal microsomal antibodies in patients with hyperthyroidism due to Graves' disease treated with antithyroidal drugs.
    J Clin Endocrinol Metab. 1989; 68: 1093-1100
    • Google Scholar
43. • Solomon B
    • Glinoer D
    • LaGasse R
    • Wartofsky L
    Current trends in the management of Graves' disease.
    J Clin Exp Med. 1990; 70: 1518-1524
    • Google Scholar
44. • Koukkou E
    • Panayiotidis P
    • Alevizou-Terzaki V
    • Thalassinos N
    High levels of serum interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism.
    J Clin Endocrinol Metab. 1991; 73: 771-776
    • Google Scholar